• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library
    Quality

    Par Pharma recalls blood pressure med for possible contamination

    FIERCE PHARMA

    Par Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection

    PR NEWSWIRE

    Par recalls product after glass particulate contamination

    IN -PHARMATECHNOLOGIST

    Par Pharma Issues Voluntary Recall of One Lot of Mycophenolate Mofetil for Inj

    PR NEWSWIRE

    Valsartan products not currently recalled - Updated November 27, 2018

    FDA

    Valsartan products not currently recalled - Updated August 8, 2018

    FDA

    Three Made in India drugs recalled in US: FDA

    DECCAN HERALD

    Par Pharmaceutical Inc., Ongoing Class II recall of Mafenide Acetate, USP, For 5% Topical Solution, STERILE, Net Wt. 50 grams sterile powder per packet, Rx only, PAR Pharmaceuticals label --- Distributed by: Par Pharmaceutical Companies, Inc. Spring Valley, NY 10977 Made in India -- NDC 49884-902-52 (packets of 50 g) and NDC 49884-902-78 (cartons of five 50 g packets) because of Presence of Foreign Substance; oxidized steel, organic material and shredded polypropylene

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.